Ziconotide for Management of Cancer Pain Refractory to Pharmacotherapy: An Update.

Ziconotide for Management of Cancer Pain Refractory to Pharmacotherapy: An Update. Pain Med. 2020 12 25; 21(12):3253-3259.

View in: PubMed